National concensus in cystic fibrosis;Consenso nacional de fibrosis quística

Revista Chilena de Pediatria

Volumn 72, Issue 4, 2001, Pages 356-380

  Sanchez I D ^a   Perez M A H ^a   Boza, M L C ^a   Lezana, V S ^a   Vila, M A I ^a   Repetto, G L ^a   Hodgson, M I B ^a   Rios G M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; AZTREONAM; BRONCHODILATING AGENT; CARBENICILLIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; FLUCLOXACILLIN; IBUPROFEN; IMIPENEM; MUCOLYTIC AGENT; PENICILLIN DERIVATIVE; STEROID; TOBRAMYCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; VANCOMYCIN;

CLINICAL FEATURE; CYSTIC FIBROSIS; DIAGNOSTIC APPROACH ROUTE; GASTROINTESTINAL SYMPTOM; GENE MUTATION; GENETIC ANALYSIS; KINESIOTHERAPY; LABORATORY TEST; MECONIUM ILEUS; NUTRITION; RESPIRATORY TRACT INFECTION; REVIEW; TREATMENT INDICATION;

EID: 0035190769     PISSN: 03704106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Identification of the cystic fibrosis gene; Chromosome walking and jumping
2. Fibrosis quistica: Una enfermedad emergente
3. The diagnosis of cystic fibrosis: A consensus statement
4. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening
5. CFTR mutations in three Latin American countries
6. Genotype and phenotype in cystic fibrosis
7. CFTR mutations in Chilean cystic fibrosis patients
8. Estudio genético molecular de la fibrosis quistica en la V Región, Chile
9. Identificación de mutaciones en el gen CFTR en pacientes chilenos con fibrosis quística
10. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis
11. Comprehensive mutation screening in a cystic fibrosis center
12. The diagnosis of cystic fibrosis
13. Consenso de fibrosis quistica
14. Comparación entre dos métodos de determinación del test del sudor en el diagnóstico de la fibrosis quística
15. Sweat testing for the diagnosis of cystic fibrosis. Practical considerations
16. Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis
17. State of the art: Cystic fibrosis
18. Diagnosis and treatment of cystic fibrosis
19. Pathogenesis of lung disease in cystic fibrosis
20. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis
21. Implications of early inflammation and infection in cystic fibrosis: A review of new and potential interventions
22. Cystic fibrosis foundation guidelines for patient services, evaluation, and monitoring in cystic fibrosis centers
23. Outcome measures for clinical trials in cystic fibrosis. Summary of a cystic fibrosis foundation consensus conference
24. Evaluation of a scoring system of the chest radiographs in cystic fibrosis: Collaborative study
25. Treatment of Pseudomonas aeruginosa: The European perspective
26. Management of pulmonary disease in patients with cystic fibrosis
27. Advances in cystic fibrosis
28. State of the art: Cystic fibrosis
29. Fibrosis quistica: Logrando una sobrevida cada vez mayor
30. The Consensus Committee: Nutritional assessment in cystic fibrosis: A consensus report
31. Nutritional imperatives in cystic fibrosis therapy
32. New Development in cystic fibrosis
33. Comparison of weight based dosages of enteric coated micro tablet enzyme preparations in patients with cystic fibrosis
34. Use of pancreatic enzyme supplements for patients with Cystic Fibrosis in the context of fibrosis colonopathy
35. Nutritional management of cystic fibrosis
36. Vitamin E deficiency and neurological disease in adults with cystic fibrosis
37. Vitamin K status in cystic fibrosis
38. Vitamin E supplementation in cystic fibrosis
39. Low plasma zinc concentrations in young infants with cystic fibrosis
40. Functional iron deficiency in adults with cystic fibrosis
41. Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus
42. Abdominal calcification in cystic fibrosis with meconium ileus. Radiologic-pathologic correlation
43. Cystic fibrosis. Gastrointestinal complications and gene therapy
44. Gastrointestinal manifestations of cystic fibrosis
45. Recommendation for management of liver and biliary tract disease in cystic fibrosis
46. Adequacy of clinical formulae for estimation of energy requirements in children with cystic fibrosis
47. Nutrition intervention for weight gain in cystic fibrosis: A Meta analysis
48. Oral calorie supplements for cystic fibrosis
49. Enteral tube feeding for cystic fibrosis